Horizon Discovery completes placing ahead of Dharmacon acquisition
Horizon Discovery Group
184.50p
16:59 23/12/20
0.00%
0.00p
Gene editing technology company Horizon Discovery Group confirmed on Wednesday that 39,024,390 placing shares had now been admitted to trading on AIM, raising gross proceeds of £80m.
FTSE AIM 100
3,641.16
11:25 25/04/24
n/a
n/a
FTSE AIM All-Share
755.23
11:25 25/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,746.08
11:25 25/04/24
3.88%
848.58
The AIM-traded firm said following that, it expected completion of its acquisition of GE Healthcare Dharmacon to occur on 31 August.
Following the admission of the placing shares, the company's enlarged issued share capital now comprised 135,851,082 ordinary shares with one voting right per share.
“No shares are held in treasury,” the board clarified, adding that “the total number of voting rights in the company is therefore 135,851,082.”